The aim of EPISTOP is to better understand the pathophysiology of epilepsy and its consequences, to develop a preventative strategy for epilepsy, to identify new biomarkers of epilepsy, and to develop new therapeutic targets to block or otherwise modify epileptogenesis in humans.

To achieve this aim, the risk factors and biomarkers of epilepsy will be identified by a multidisciplinary, systematic approach in three settings: